Atopic dermatitis (eczema)

Home

All internal pages:

• Archives
• Sitemap
• About
• Disclaimer

All internal blog posts:

• A 20-year analysis of previous and emerging allergens that elicit photoallergic contact dermatitis. 0
• Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months. 0
• Cystic fibrosis presenting with dermatitis. 0
• Nickel allergy presenting as mobile phone contact dermatitis. 0
• Defining the Antigen Determinant for T-Cell-Mediated Contact Dermatitis Using p-Phenylenediamine: A Gateway to Chemical Immunology. 0
• Comparative molecular analysis of methicillin-resistant Staphylococcus aureus isolates from atopic dermatitis children and healthy subjects in Taiwan. 0
• Enhanced Expression and Secretion of Antimicrobial Peptides in Atopic Dermatitis and after Superficial Skin Injury. 0
• Efficacy of a 5-HT receptor agonist in atopic dermatitis. 0
• Breastfeeding and atopic dermatitis: protective or harmful? facts and controversies. 0
• The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies. 0
• The historical basis of a misconception leading to undertreating atopic dermatitis (eczema):facts and controversies. 0
• Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. 0
• Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversies. 0
• Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. 0
• Successful treatment of lichen amyloidosus associated with atopic dermatitis using a combination of narrowband ultraviolet B phototherapy, topical corticosteroids and an antihistamine. 0
• A case report and critical appraisal of the literature on the use of DermaSilk in children with atopic dermatitis. 0
• Systemic allergic contact dermatitis due to consumption of raw shiitake mushroom. 0
• Transfer contact dermatitis caused by rosin use in bowling. 0
• Facial corticosteroid addictive dermatitis in Guiyang City, China. 0
• No Increased Risk of Cancer after Coal Tar Treatment in Patients with Psoriasis or Eczema. 0
• FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. 0
• Case of autoimmune progesterone dermatitis presenting as fixed drug eruption. 0
• Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib. 0
• No association between nickel allergy and reporting cosmetic dermatitis from mascara or eye shadow: a cross-sectional general population study. 0
• Initial presentation of stasis dermatitis mimicking solitary lesions: A previously unrecognized clinical scenario. 0
• The effect of tobacco smoking and alcohol consumption on the prevalence of self-reported hand eczema: a cross-sectional population-based study. 0
• Granulomatous dermatitis with pseudoxanthoma elasticum-like changes: report of a case in a patient with cystic fibrosis. 0
• An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. 0
• Successful retreatment with alitretinoin in relapsed chronic hand eczema patients. 0
• Increased expression of glucocorticoid receptor beta in lymphocytes of patients with severe atopic dermatitis unresponsive to topical corticosteroid. 0
• Interstitial granulomatous dermatitis with arthritis. 0
• Health behaviour models: a framework for studying adherence in children with atopic dermatitis. 0
• Seborrhoeic dermatitis among Oxford renal transplant recipients. 0
• Perinatal exposure to endotoxin and the development of eczema during the first 6 years of life. 0
• Prednisolone versus cyclosporine for severe adult eczema. An investigator-initiated double-blind placebo controlled multi-centre trial. 0
• What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment. 0
• What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema. 0
• Increased serum B cell-activating factor level in children with atopic dermatitis. 0
• Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. 0
• A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. 0
• Late-onset of IgE sensitization to microbial allergens in young children with atopic dermatitis. 0
• A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis. 0
• Corticosteroids’ effect on the height of atopic dermatitis patients: a controlled questionnaire study. 0
• Twice-daily versus Once-daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis. 0
• Lyme disease as a cause of acropapular dermatitis of childhood. 0
• Protein losing enteropathy in severe atopic dermatitis in an exclusively breast-fed infant. 0
• Homoeopathic versus Conventional Therapy for Atopic Eczema in Children: Medical and Economic Results. 0
• Allergic contact dermatitis to inhalation corticosteroids. 0
• Molecular Diagnostics of Psoriasis, Atopic Dermatitis, Allergic Contact Dermatitis and Irritant Contact Dermatitis. 0
• The central role of Bcl-3 in atopic dermatitis. 0
• Steroid-induced Periorificial Dermatitis in Children-Clinical Features and Response to Azelaic Acid. 0
• Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year. 0
• A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis. 0
• Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis. 0
• An outbreak of furniture related dermatitis (’sofa dermatitis’) in Finland and the UK: history and clinical cases. 0
• An epidemic of furniture-related dermatitis: searching for a cause. 0
• Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden - with model applications for Denmark, Norway and Finland. 0
• Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis. 0
• An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence-based medicine. 0
• Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors. 0
• Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. 0
• Guidelines for management of atopic dermatitis. 0
• Dermatitis cruris pustulosa et atrophicans revisited: our experience with 37 patients in south India. 0
• 5-methoxypsoralen plus UVA is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis. A randomized crossover trial. 0
• Genetic and Environmental Risk Factors for Childhood Eczema Development and Allergic Sensitization in the CCAAPS Cohort. 0
• Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study. 0
• Consensus statement on the management of chronic hand eczema. 0
• Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis. 0
• ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. 0
• Fluocinolone acetonide 0.01% in peanut oil: safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age. 0
• Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. 0
• Patch test reaction on Ethiopian subjects with eczema. 0
• Dermatitis artefacta of the breast: a retrospective analysis of 27 patients (1976-2006). 0
• Dental infection associated with nummular eczema as an overlooked focal infection. 0
• Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. 0
• Delay in medical attention to hand eczema: a follow-up study. 0
• Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients. 0
• Low bone mineral density in adult patients with moderate to severe atopic dermatitis. 0
• Inflammatory epidermolysis bullosa acquisita mimicking toxic epidermal necrolysis and dermatitis herpetiformis. 0
• Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. 0
• Sites of dermatitis in a patch test population: hand dermatitis is associated with polysensitization. 0
• FLG mutation p.Lys4021X in the C-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. 0
• Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity. 0
• What causes flares of eczema in children? 0
• Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions. 0
• Prevalence of nickel and cobalt allergy among female patients with dermatitis before and after Danish government regulation: A 23-year retrospective study. 0
• Psychiatric comorbidity in adult eczema. 0
• Prevalence of adult atopic dermatitis among nursing staff in a Taiwanese medical center: A pilot study on validation of diagnostic questionnaires. 0
• Future perspectives in the treatment of atopic dermatitis. 0
• Staphylococcus aureus and hand eczema severity. 0
• Topical treatment of perianal eczema with tacrolimus 0.1% 0
• Palisaded neutrophilic granulomatous dermatitis associated with systemic lupus erythematosus presenting with the burning rope sign. 0
• Human T-cell lymphotropic virus type 1 infective dermatitis emerging in adulthood. 0
• Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. 0
• Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults. 0
• Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. 0
• Dermatological future of european patients with atopic dermatitis. 0
• Brain-derived neurotrophic factor gene polymorphisms and serum levels in Chinese atopic dermatitis patients. 0
• Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis. 0
• Canine Models of Atopic Dermatitis: A Useful Tool with Untapped Potential. 0
• Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. 0
• Measurement of nitric oxide and 8-isoprostane in exhaled breath of children with atopic eczema. 0
• Estimating emollient usage in patients with eczema. 0
• Dermatitis papulosa adultorum. 0
• Epidermal Barrier Dysfunction in Atopic Dermatitis. 0
• How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. 0
• Is Demodex folliculorum an aetiological factor in seborrhoeic dermatitis? 0
• Analysis of the prodynorphin promoter polymorphism in atopic dermatitis and disease-related pruritus. 0
• Dermatitis from plants of the new world. 0
• Guidelines for the diagnosis and treatment of dermatitis herpetiformis. 0
• Superimposed segmental dermatitis with chronic prurigo. 0
• Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. 0
• Allergic and irritant contact dermatitis. 0
• Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD). 0
• The cystatin M / E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. 0
• Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. 0
• Localized acquired cutis laxa secondary to interstitial granulomatous dermatitis. 0
• Risk factors for severe impetiginized atopic dermatitis in Japan and assessment of its microbiological features. 0
• Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. 0
• The prevalence, characteristics of and risk factors for eczema in Belgian schoolchildren. 0
• Diffuse xanthogranulomatous dermatitis and systemic Langerhans cell histiocytosis: A novel case that demonstrates bridging between non-Langerhans cell histiocytosis and Langerhans cell histiocytosis. 0
• The relationship between sensory hypersensitivity and sleep quality of children with atopic dermatitis. 0
• Effects of skin care with shower therapy on children with atopic dermatitis in elementary schools. 0
• Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. 0
• Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. 0
• Clinical severity and prognosis of hand eczema. 0
• Current acceptance and implementation of preventive strategies for occupational hand eczema in 1355 metalworkers in Germany. 0
• Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc-based treatments? 0
• IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis. 0
• Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. 0
• Eczema workshops reduce severity of childhood atopic eczema. 0
• Allergic contact dermatitis from exposure to Grevillea robusta in New Zealand. 0
• Periocular dermatitis: a report of 401 patients. 0
• Contact dermatitis in car repair workers. 0
• Atopic dermatitis and risk factors in poor children from Great Buenos Aires, Argentina. 0
• Cercarial dermatitis in the UK. 0
• Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. 0
• First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study. 0
• Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. 0
• Nurses’ perceptions of the benefits and adverse effects of hand disinfection: alcohol-based hand rubs vs. hygienic handwashing: a multicentre questionnaire study with additional patch testing by the German Contact Dermatitis Research Group. 0
• Itch characteristics in atopic dermatitis: results of a web-based questionnaire. 0
• Does tobacco smoking influence the occurrence of hand eczema? 0
• Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. 0
• Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis. 0
• Neuroselective transcutaneous electrical stimulation reveals neuronal sensitization in atopic dermatitis. 0
• Allergic contact dermatitis from temporary henna tattoo. 0
• Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. 0
• Infective dermatitis. 0
• The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. 0
• The Role of Leukocytes, Keratinocytes, and Allergen-Specific IgE in the Development of Atopic Dermatitis. 0
• Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride. 0
• Occupational dermatitis to epoxydic and phenolic resins. 0
• Clinical Expression of Nickel Contact Dermatitis Primed by Diagnostic Patch Test. 0
• New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. 0
• Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. 0
• The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis. 0
• Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis. 0
• Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis. 0
• Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study. 0
• Effect of rosmarinic acid on atopic dermatitis. 0
• Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. 0
• Guidelines for the management of contact dermatitis: an update. 0
• Hand eczema and quality of life: a population-based study. 0
• Hand dermatitis and lymphoedema. 0
• Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. 0
• Are there predominant strains and toxins of Staphylococcus aureus in atopic dermatitis patients? Genotypic characterization and toxin determination of S. aureus isolated in adolescent and adult patients with atopic dermatitis. 0
• Fluoroscopy-induced chronic radiation dermatitis: a report of three cases. 0
• Allergic contact dermatitis to pure henna. 0
• Photoallergic contact dermatitis caused by ultraviolet filters in different sunscreens. 0
• Clinical severity correlates with impaired barrier in filaggrin-related eczema. 0
• Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. 0
• The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. 0
• Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. 0
• Eczema genetics: current state of knowledge and future goals. 0
• Contact allergy in chronic eczematous lip dermatitis. 0
• Photocontact dermatitis to ketoprofen presenting with erythema multiforme. 0
• Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. 0
• Periorificial dermatitis in children: an update and description of a child with striking features. 0
• Low risk of melanoma in patients with atopic dermatitis. 0
• B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up. 0
• Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. 0
• The course of life of patients with childhood atopic dermatitis. 0
• May the gender of a parent influence assessment of health-related quality of life, family impact and severity of atopic dermatitis in children? 0
• A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. 0
• Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. 0
• Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. 0
• Dermatitis associated with exposure to a marine cyanobacterium during recreational water exposure. 0
• Neonatal colonization with Staphylococcus aureus is not associated with development of atopic dermatitis. 0
• Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. 0
• Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis. 0
• Validity and responsiveness of the Osnabrück Hand Eczema Severity Index (OHSI): a methodological study. 0
• Antisense Targeting of cFLIP Sensitizes Activated T Cells to Undergo Apoptosis and Desensitizes Responses to Contact Dermatitis. 0
• Is contact allergy to disperse dyes and related substances associated with textile dermatitis? 0
• Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck. 0
• Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis. 0
• Prevalence and molecular characteristics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore. 0
• Evaluation of out-in skin transparency using a colorimeter and food dye in patients with atopic dermatitis. 0
• Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion. 0
• Tolerance of Oat-Based Topical Products in Cereal-Sensitized Adults with Atopic Dermatitis. 0
• Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. 0
• A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis. 0
• An outbreak of 268 cases of Paederus dermatitis in a toy-building factory in central China. 0
• Use of a silklike bedding fabric in patients with atopic dermatitis. 0
• Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. 0
• Occupational carprofen photoallergic contact dermatitis. 0
• Whither… the future for contact dermatitis? A report from the 2007 International Review of Current Problems in Contact Dermatitis. 0
• Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. 0
• Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. 0
• Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. 0
• Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. 0
• Congenital mucinous eccrine nevus in a 5-month-old girl with frequent intertriginous dermatitis. 0
• Nickel allergy as risk factor for hand eczema: a population-based study. 0
• Incidence of chickenpox in young South Korean soldiers and correlation with atopic dermatitis. 0
• Maintenance of an Acidic Stratum Corneum Prevents Emergence of Murine Atopic Dermatitis. 0
• Suprabasal Spongiosis in Acute Eczematous Dermatitis: cFLIP Maintains Resistance of Basal Keratinocytes to T-Cell-Mediated Apoptosis. 0
• Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. A randomised controlled trial. 0
• Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. 0
• Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. 0
• The role of Malassezia in atopic dermatitis affecting the head and neck of adults. 0
• Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis. A Preliminary Feasibility Study. 0
• Two pediatric cases of nonbullous histiocytoid neutrophilic dermatitis presenting as a cutaneous manifestation of lupus erythematosus. 0
• Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis. 0
• Atopic dermatitis: a disease caused by innate immune defects? 0
• Clinical analyses of atopic dermatitis in the aged. 0
• What’s new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007. 0
• CD40 expression on antigen presenting cells and correlation with disease severity in atopic dermatitis. 0
• Association factors for atopic dermatitis in nursery school children in Ishigaki islands - Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). 0
• Does age or gender influence quality of life in children with atopic dermatitis? 0
• Further experience of using azathioprine in the treatment of severe atopic dermatitis. 0
• Interstitial granulomatous dermatitis: a misdiagnosed cutaneous form of systemic lupus erythematosus? 0
• Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. 0
• Animal models of atopic dermatitis. 0
• Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis. 0
• Prognostic factor of adult patients with atopic dermatitis. 0
• Possible pathogenic role of Th17 cells for atopic dermatitis. 0
• A role for Th17 cells in the immunopathogenesis of atopic dermatitis? 0
• Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. 0
• The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer. 0
• Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis. 0
• Patch Tests in Children with Suspected Allergic Contact Dermatitis: A Prospective Study and Review of the Literature. 0
• Traffic-related air pollution, climate, and prevalence of eczema in Taiwanese school children. 0
• An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”. 0
• Role of foods in irregular aggravation of skin lesions in children with atopic dermatitis. 0
• Contact allergy in children referred for patch testing: north american contact dermatitis group data, 2001-2004. 0
• Systemic therapy of paediatric atopic dermatitis: an update. 0
• Kaposi varicelliform eruption (eczema herpeticum). 0
• Interstitial granulomatous dermatitis. 0
• Chronic actinic dermatitis. 0
• Lymphocyte proliferation testing in chromium allergic contact dermatitis. 0
• Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. 0
• Amyopathic dermatomyositis resembling stasis dermatitis. 0
• The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. 0
• A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis. 0
• Periorbital dermatitis-a recalcitrant disease: causes and differential diagnoses. 0
• Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis. 0
• ILVEN-like persistent psoriasiform dermatitis confined to a congenital Becker nevus. 0
• Epidemiology of atopic dermatitis in primary schoolchildren in Turkey. 0
• Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy. 0
• Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. 0
• Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons. 0
• Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 0
• Investigation of the eotaxin gene -426C–>T, -384A–>G and 67G–>a single-nucleotide polymorphisms and atopic dermatitis in Italian children using family-based association methods. 0
• Stasis dermatitis-like leukaemic infiltration in a patient with myelodysplastic syndrome. 0
• House dust mites on skin, clothes, and bedding of atopic dermatitis patients. 0
• Heliotherapy improves vitamin D balance and atopic dermatitis. 0
• Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. 0
• In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis. 0
• Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood. 0
• Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides. 0
• Quality of life in patients with facial steroid dermatitis before and after treatment. 0
• Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. 0
• Medical consultations in relation to severity of hand eczema in the general population. 0
• Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. 0
• Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. 0
• Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. 0
• Diagnostic criteria for atopic dermatitis: a systematic review. 0
• Contact and aeroallergens in adulthood atopic dermatitis. 0
• Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells. 0
• Eczema and X-linked agammaglobulinaemia. 0
• Does autonomic dysfunction play a role in atopic dermatitis? 0
• Prophylactic effect of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice. 0
• Facing psoriasis and atopic dermatitis: are there more similarities or more differences? 0
• Alefacept for moderate to severe atopic dermatitis: a pilot study in adults. 0
• Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. 0
• A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. 0
• Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. 0
• Common misconceptions in contact dermatitis counseling. 0
• Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis. 0
• A multicentre randomized controlled trial of ion-exchange water softeners for the treatment of eczema in children: protocol for the Softened Water Eczema Trial (SWET) (ISRCTN: 71423189). 0
• Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata. 0
• Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. 0
• Patch testing a patient with allergic contact hand dermatitis who is taking infliximab. 0
• A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. 0
• Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: implications for allergic respiratory disease and prognosis. 0
• A Randomized Double-Blind Study to Investigate the Clinical Efficacy of Adding a Non-Migrating Antimicrobial to a Special Silk Fabric in the Treatment of Atopic Dermatitis. 0
• Dermatitis cruris pustulosa et atrophicans–a frequent but poorly understood tropical skin condition–a case report from Burkina Faso. 0
• AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. 0
• ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis. 0
• Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. 0
• Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. 0
• Morbidity and cost of atopic eczema in Australia. 1
• Allergic contact dermatitis caused by the clothing dye, disperse blue 106, an important contact allergen that may be frequently missed. 0
• Severe contact dermatitis as a result of an antiseptic bath oil. 2
• StabiEL: Stabilization of skin condition with Elidel - a patients’ satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid. 0
• CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. 0
• Written action plans: Potential for improving outcomes in children with atopic dermatitis. 0
• Nickel earlobe dermatitis and clinical non-relevance of the oral exposure. 0
• The efficacy of ‘0.05% Clobetasol + 2.5% zinc sulphate’ cream vs. ‘0.05% Clobetasol alone’ cream in the treatment of the chronic hand eczema: a double-blind study. 0
• Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. 0
• Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen. 0
• Modeling atopic dermatitis with increasingly complex mouse models. 0
• “Outside-to-inside” (and now back to “outside”) pathogenic mechanisms in atopic dermatitis. 0
• Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. 0
• Prevalence and risk factors for atopic dermatitis in preschool children. 0
• Autoimmune progesterone dermatitis. Case report with histologic overlap of erythema multiforme and urticaria. 0
• Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva). 0
• Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. 0
• Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. 0
• Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis. 0
• Irritant contact dermatitis: a review. 0
• Fingertip dermatitis refractory to topical corticosteroids associated with nail-patella syndrome. 0
• Filaggrin null alleles are not associated with hand eczema or contact allergy. 0
• Environmental factors, parental atopy and atopic eczema in primary-school children: a cross-sectional study in Taiwan. 0
• Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. 0
• Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. 0
• The socioeconomic impact of atopic dermatitis in the United States: a systematic review. 0
• Atopic dermatitis among 2-year olds; high prevalence, but predominantly mild disease–the PACT study, Norway. 0
• Bleomycin-induced flagellate dermatitis. 0
• Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. 0
• The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. 0
• A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. 0
• A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). 0
• Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients. 0
• Contact dermatitis: epidemiology and frequent sensitizers to cosmetics. 0
• Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. 0
• Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. 0
• Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. 0
• Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: a double-blind, placebo-controlled clinical trial. 0
• Sanitary napkin contact dermatitis of the vulva: location-dependent differences in skin surface conditions may play a role in negative patch test results. 0
• Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study. 0
• The role of selected neuropeptides in pathogenesis of atopic dermatitis. 0
• Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). 0
• The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. 0
• Clinical differences between atopic and atopiform dermatitis. 0
• Disease severity, scratching, and sleep quality in patients with atopic dermatitis. 0
• Lichenoid and other clinical presentations of atopic dermatitis in an inner city practice. 0
• Prognosis of unclassified eczema: a follow-up study. 0
• Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis? 0
• Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients. 0
• The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema. 0
• Assessment of atopic eczema: clinical scoring and noninvasive measurements. 0
• Flexural allergic contact dermatitis to benzalkonium chloride in antiseptic bath oil. 0
• Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. 0
• Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. 0
• Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. 0
• Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. 0
• Hypersensitivity to aeroallergens in adult patients with atopic dermatitis develops due to the different immunological mechanisms. 0
• Diffuse dermatitis: An unexpected initial presentation of cystic fibrosis. 0
• A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis. 0
• Frequency of allergic contact dermatitis to isoeugenol is increasing: a review of 3636 patients tested from 2001 to 2005. 0
• On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. 0
• Increased lipopolysaccharide-induced tumour necrosis factor-alpha, interferon-gamma and interleukin-10 production in atopic dermatitis. 0
• Occupational dermatitis related to chromium and cobalt: experience of dermatologists (EPIDERM) and occupational physicians (OPRA) in the U.K. over an 11-year period (1993-2004). 0
• Incidence of hand eczema in a population-based twin cohort: genetic and environmental risk factors. 0
• Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). 0
• Topical tacrolimus treatment for chronic dermatitis of the ear. 0
• Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders. 0
• Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. 0
• Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients. 0
• Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema. 0
• Allergic contact dermatitis to topical antibiotics: Epidemiology, responsible allergens, and management. 0
• The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. 0
• The role of furry pets in eczema: a systematic review. 0
• Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. 0
• Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. 0
• Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. 0
• Single nucleotide polymorphism-based genome-wide linkage analysis in Japanese atopic dermatitis families. 0
• Dermatitis artefacta in a child. 0
• Diaper dermatitis-frequency and contributory factors in hospital attending children. 0
• Getting more and more complex: the pathophysiology of atopic eczema. 0
• Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study. 0
• Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. 0
• Use of complementary and alternative treatment for allergic contact dermatitis. 0
• Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. 0
• No significant increase within a 3-year interval in the prevalence of atopic dermatitis among schoolchildren in Baranya County, Hungary. 0
• Port-wine-stain-associated dermatitis: implications for cutaneous vascular laser therapy. 0
• Atopic Dermatitis. How is it diagnosed? 2
• Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. 0
• Filaggrin mutations in children with severe atopic dermatitis. 0
• The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy. 0
• Contact dermatitis in athletes. 0
• Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. 0
• Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. 0
• Distribution to the skin of epinastine hydrochloride in atopic dermatitis patients. 0
• Establishment of a mouse skin model of the lichenification in human chronic eczematous dermatitis. 0
• Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study. 0
• A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. 0
• Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis. 0
• Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis. 0
• Progesterone sensitive Interferon-gamma producing cells detected by ELISpot assay in autoimmune progesterone dermatitis. 0
• Association of toll-interacting protein gene polymorphisms with atopic dermatitis. 0
• Pseudocysts of the auricle in a young adult with facial and ear atopic dermatitis. 0
• Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome. 0
• Kumkum-induced dermatitis: an analysis of 46 cases. 0
• Which aeroallergens are associated with eczema severity? 0
• Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis. 0
• Antipsoriatic biologic agents for the treatment of atopic dermatitis. 0
• Odontogenic focal infection could be partly involved in the pathogenesis of atopic dermatitis as exacerbating factor. 0
• An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. 0
• Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. 0
• Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: a community-based clinical survey. 0
• Acetylator phenotype in Iraqi patients with atopic dermatitis. 0
• Paederus dermatitis in Sierra Leone. 0
• Papulosquamous dermatitis. Syphilis: a forgotten disease? 0
• Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis. 0
• The use of alternative medicine in pediatric patients with atopic dermatitis. 0
• Hand eczema extent and morphology–association and influence on long-term prognosis. 0
• Early lesion of palisaded neutrophilic granulomatous dermatitis in ulcerative colitis. 0
• Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. 0
• An outbreak of Paederus dermatitis in a suburban hospital in South India: a report of 123 cases and review of literature. 0
• Filaggrin’s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. 0
• Perforating neutrophilic and granulomatous dermatitis of the newborn–a clue to immunodeficiency. 0
• Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis. 0
• Dermatitis artefacta in a 12-year-old girl mimicking cutaneous T-cell lymphoma. 0
• “Unknown Risks” of non-steroid topical medications for atopic dermatitis. 0
• Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004. 0
• Hand eczema is common and multifactorial. 0
• The sensory profile of children with atopic dermatitis as determined by the sensory profile questionnaire. 0
• Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. 0
• Outbreak report of airborne caterpillar dermatitis in a kindergarten. 0
• Predictive clinical features of eczema craquelé associated with internal malignancy. 0
• Outbreak of tropical rat mite (Ornithonyssus bacoti) dermatitis in a home for disabled persons. 0
• Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. 0
• Gene expression time course in the human skin during elicitation of allergic contact dermatitis. 0
• Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. 0
• Relationship between Kaposi’s varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region. 0
• Atopic dermatitis: impact on the quality of life of patients and their partners. 0
• Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis. 0
• Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus. 0
• Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis. 0
• Effective therapy of childhood atopic dermatitis allays food allergy concerns. 0
• Development of atopic dermatitis-specific communication tools: Interview form and question and answer brochure. 0
• Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. 0
• Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga. 0
• Compositae dermatitis from airborne parthenolide. 0
• Unnecessary milk elimination diets in children with atopic dermatitis. 0
• Pigmentary changes and atopic dermatitis in a patient with Seckel syndrome. 0
• Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitis. 0
• National Eczema Association and topical calcineurin inhibitor labeling. 0
• Vitiliginous lesions after photosensitive dermatitis due to flutamide. 0
• Interstitial granulomatous dermatitis associated with autoimmune hepatitis. 0
• Pustular allergic contact dermatitis from topical minoxidil 5%. 0
• Irritant contact dermatitis from exposure to povidone-iodine may resemble toxic epidermal necrolysis. 0
• Cutaneous Lichenoid dermatitis associated with imatinib mesylate. 0
• Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate. 0
• When and how to perform allergy tests in children and adults with atopic dermatitis. 0
• Localized linear IgA disease showing contact dermatitis-like eruption. 0
• Occupational allergic contact dermatitis to cresyl glycidyl ether (CGE). 0
• Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute. 0
• What do you mean by eczema craquelé? 0
• Urachal sinus presenting as periumbilical dermatitis. 0
• Undershirts coated with borage oil alleviate the symptoms of atopic dermatitis in children. 0
• Hand eczema prognosis. 0
• Long-term follow-up of a child treated with efalizumab for atopic dermatitis. 0
• Tacrolimus ointment in onychodystrophy associated with eczema. 0
• A pilot open trial evaluating the efficacy of low-dose aminopterin in the canine homologue of human atopic dermatitis. 0
• Facial eruption of viral warts in a child treated with 0.03% tacrolimus ointment for atopic dermatitis. 0
• Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide. 0
• Allergic contact dermatitis: another adverse effect of over-the-counter topical hydrocortisone. 0
• Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab. 0
• Recurrent dermatitis after solitary envenomation by jellyfish partially responded to tacrolimus ointment 0.1%. 0
• Contact dermatitis. 0
• Atopic dermatitis. 0
• Annular lichenoid dermatitis of youth. 0
• What’s in a moisturising cream? 1
• Topical pimecrolimus for eczema. 0
• Photosensitivity dermatitis from inadvertent exposure to aminolevulinic acid. 0
• Good skin care product ingredients 1
• Occupational allergic contact dermatitis to methyldibromoglutaronitrile in hand degreasing toilet paper. 0
• Allergic contact dermatitis from rabbit’s feed. 0
• Lymphomatoid contact dermatitis to an exotic wood: a very harmful toilet seat. 0
• Cellular phone addiction and allergic contact dermatitis to nickel. 0
• Allergic contact dermatitis due to rubber in sports equipment. 0
• WITHDRAWN: Maternal antigen avoidance during lactation for preventing atopic eczema in infants. 0
• Psychological and educational interventions for atopic eczema in children. 0
• Risk of developing asthma in young children with atopic eczema: a systematic review. 0
• Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-gamma production by peripheral blood CD4(+) and CD8(+) T cells. 0
• Change in co-editor for Contact Dermatitis. 0
• Airborne irritant contact dermatitis and conjunctivitis after occupational exposure to chlorothalonil in textiles. 0
• Prevalence and 1-year outcome of facial allergic contact dermatitis in patients patch tested in a university hospital. 0
• Contact dermatitis from violet fragrance in a florist. 0
• Bilateral palmar dermatitis possible caused by computer wrist rest. 0
• Allergic contact dermatitis to ethylhexylglycerin in a cream. 0
• Allergic contact dermatitis as a result of diethylthiourea. 0
• Allergic contact dermatitis from toluene-2,5-diamine in a cream dye for eyelashes and eyebrows–quantitative exposure assessment. 0
• Allergic contact dermatitis produced by canrenone. 0
• Contact dermatitis from amulet. 0
• Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. 0
• Serotonergic mechanisms in human allergic contact dermatitis. 0
• Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. 0
• Patchy eczema of elderly patients. 0
• Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI. 0
• Genetics of nickel allergic contact dermatitis. 0
• Prevalence of hand dermatitis in inpatient nurses at a United States hospital. 0
• Hand dermatitis in auto mechanics and machinists. 0
• Sensitivity of Petrolatum and Aqueous Vehicles for Detecting Allergy to Imidazolidinylurea, Diazolidinylurea, and DMDM Hydantoin: A Retrospective Analysis from the North American Contact Dermatitis Group. 0
• Cyclosporin a treatment is associated with increased serum immunoglobulin e levels in a subgroup of atopic dermatitis patients. 0
• Joint meeting of the experimental contact dermatitis research group and the american contact dermatitis society in Baltimore, MD, september 28 to 30, 2006. 0
• Atopic dermatitis and Valpha24+ natural killer T cells. 0
• Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. 0
• A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. 0
• Management of chronic hand eczema. 0
• Incontinence in the aged: contact dermatitis and other cutaneous consequences. 0
• Retesting with the TRUE Test((R)) in a population-based twin cohort with hand eczema - allergies and persistence in an 8-year follow-up study. 0
• Occupational allergic contact dermatitis caused by aerosols of acrylate monomers. 0
• Allergic contact dermatitis caused by tosylamide formaldehyde resin in nail varnish: an old allergen that has not disappeared. 0
• Allergic contact dermatitis to Aloe vera. 0
• Contact dermatitis due to Allivum sativum and Ranunculus illyricus: two cases. 0
• Allergic contact dermatitis to cod liver oil contained in a topical ointment. 0
• Simvastatin - occupational contact dermatitis. 0
• Contact dermatitis to hydrolyzed wheat protein. 0
• Occupational airborne contact dermatitis from saffron bulbs. 0
• A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. 0
• Bifidobacterium pseudocatenulatum is associated with atopic eczema: A nested case-control study investigating the fecal microbiota of infants. 0
• What are the best outcome measurements for atopic eczema? A systematic review. 0
• Topical tacrolimus in the treatment of atopic dermatitis-does it benefit the airways? A 4-year open follow-up. 0
• Oat sensitization in children with atopic dermatitis: prevalence, risks and associated factors. 0
• Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. 0
• Airborne occupational allergic contact dermatitis from coal dust. 0
• Filaggrin Gene Mutations Mediate Severity of Alopecia Areata When Associated with Atopic Dermatitis. 0
• Microbial allergen-specific IgE is not suitable to identify the intrinsic form of atopic eczema in children. 0
• Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. 0
• Pesticide contact dermatitis in fruit and vegetable farmers of Himachal Pradesh (India). 0
• Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients. 0
• Are material safety data sheets (MSDS) useful in the diagnosis and management of occupational contact dermatitis? 0
• Contact dermatitis as a result of Urginea maritima. 0
• Allergic contact dermatitis from ethylcyanoacrylate in an office worker with artificial nails led to months of sick leave. 0
• Allergic contact dermatitis caused by poly(adipic acid-co-1,2-propylene glycol) and di-(n-octyl) tin-bis(2-ethylhexylmaleate) in vinyl chloride gloves. 0
• Fiberglass dermatitis microepidemic in a primary school. 0
• What is Cradle Cap? 0
• Dyshidrotic eczema (pompholyx) 0
• Seborrheic dermatitis 1
• Perioral-nasal-ocular dermatitis 0
• Nummular eczema 0
• Seborrheic dermatitis treatment 0
• Perioral dermatitis treatment 0
• Tacrolimus (Protopic) 0
• Pimecrolimus (Elidel) 0
• Diaper Dermatitis. What causes it? 0
• Corticosteroid creams. How to use them correctly. 0
• Itching. How to relieve it. 1
• Is eczema contagious? 0
• House Dust Mite and Atopic Eczema 0
• Asteatotic dermatitis and dry skin 1
• Fed up of cream! Now what? 1
• Eczema and Food Allergy 0
• Natural vs. synthetic therapies 0

Monthly archive pages:

• February 2010
• January 2010
• December 2009
• November 2009
• October 2009
• September 2009
• August 2009
• July 2009
• June 2009
• May 2009
• April 2009
• March 2009
• February 2009
• January 2009
• December 2008
• November 2008
• October 2008
• September 2008
• August 2008
• July 2008
• June 2008
• May 2008
• April 2008
• March 2008
• February 2008
• January 2008
• December 2007
• November 2007
• October 2007
• September 2007

Topical archive pages:

• Cosmetic Ingredients
• Eczemas
• Editorials
• Research
• Therapies

Available RSS Feeds:

• RDF/RSS 1.0 feed
• RSS 0.92 feed
• RSS 2.0 feed
• Atom feed